About Us

Support Us

Research Awards
   Award Recipients
   Apply for an Award

   Clinical Network
   Preclinical Screening

News Room
   What's New
   Advance Newsletter
   In the News
   Media Kit

   Learn from the Experts
   Clinical Trials
   Additional Resources

Contact Us


Project Awards


Investigator Institution Project

Tom Curran, PhD


St. Jude Children's
Research Hospital


Use of a novel SHH pathway inhibitor in human medulloblastoma

Russell Matthews, PhD


Yale University


Targeting a glioma-specific isoform of BEHAB/brevican for glioma therapy

William Pardridge, MD


University of California
Los Angeles


Non-viral polygenic gene therapy of brain cancer

Paul Mischel, MD


University of California
Los Angeles


Molecular analysis of glioblastoma for kinase inhibitor therapy

John Reed, MD, PhD


The Burnham Institute


IAP antagonists for glioblastoma

Jeremy Rich, MD


Duke University


Targeting non-mitogenic receptor kinases and intracellular mediators in glioma therapy

Rosalind Segal, MD, PhD


Dana-Farber Cancer


Therapeutic use of CXCR4 antagonists in glioblastoma

Paul Workman, PhD


Institute of Cancer Research UK


Mechanism of action of novel phosphatidylinositol 3-kinase inhibitors for use in glioblastoma therapy

Margaret Wrensch, PhD


University of California
San Francisco


Evaluation of SNPs from whole genome scans in relation to glioma prognosis

Content copyright © 2008 Accelerate Brain Cancer Cure, Inc.